The rising use of additional fertility treatments with limited evidence supporting their efficacy has ignited significant debate in the field of fertility care. This research explores how a ‘hope market’ has emerged, capitalising on the promises of these new medical innovations. This research digest outlines key challenges that need to be addressed to protect patients in a market that profits from the uncertainties surrounding infertility and medical knowledge.
These issues are discussed in our Research Digest 4
"The Market for Hope: Evidence Challenges, Commercial Pressures and Patient Choices in Fertility Care" [PDF 489KB]